Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-18 Goff Brian Chief Executive Officer Exercise or conversion · Performance share units −39,000 39,000
2026-06-18 Goff Brian Chief Executive Officer Grant or award · Restricted stock units +39,000 39,000
2026-04-02 Goff Brian Chief Executive Officer Exercise or conversion 10b5-1 +25,528 190,076
2026-04-02 Goff Brian Chief Executive Officer Sale 10b5-1 −12,472 $34.71 $433K 177,604
2026-04-02 Goff Brian Chief Executive Officer Exercise or conversion 10b5-1 +13,500 191,104
2026-04-02 Goff Brian Chief Executive Officer Sale 10b5-1 −6,596 $34.71 $229K 184,508
2026-04-02 Goff Brian Chief Executive Officer Exercise or conversion · Performance share units 10b5-1 −25,528 0
2026-04-02 Goff Brian Chief Executive Officer Exercise or conversion · Performance share units 10b5-1 −13,500 40,500
2026-03-02 Goff Brian Chief Executive Officer Exercise or conversion 10b5-1 +8,500 151,603
2026-03-02 Goff Brian Chief Executive Officer Sale 10b5-1 −3,870 $28.96 $112K 147,733
2026-03-02 Goff Brian Chief Executive Officer Exercise or conversion 10b5-1 +18,000 165,733
2026-03-02 Goff Brian Chief Executive Officer Sale 10b5-1 −8,267 $28.96 $239K 157,466
2026-03-02 Goff Brian Chief Executive Officer Exercise or conversion 10b5-1 +13,000 170,466
2026-03-02 Goff Brian Chief Executive Officer Sale 10b5-1 −5,918 $28.96 $171K 164,548
2026-03-02 Goff Brian Chief Executive Officer Exercise or conversion · Restricted stock units 10b5-1 −8,500 0
2026-03-02 Goff Brian Chief Executive Officer Exercise or conversion · Restricted stock units 10b5-1 −18,000 18,000
2026-03-02 Goff Brian Chief Executive Officer Exercise or conversion · Restricted stock units 10b5-1 −13,000 26,000
2026-03-01 Goff Brian Chief Executive Officer Grant or award · Restricted stock units 10b5-1 +48,000 48,000
2026-03-01 Goff Brian Chief Executive Officer Grant or award · Stock options (right to buy) 10b5-1 +174,000 174,000
2025-12-30 Goff Brian Chief Executive Officer Exercise or conversion 10b5-1 +25,528 149,056

Page 1 of 4 · 69 trades